Ray Therapeutics

Developer of optogenetic gene therapies designed for vision restoration purposes. The company utilizes bioengineered light-sensitive proteins delivered to targeted retinal cells through intravitreal i...

Healthcare
Berkeley, CA, United States
Founded 2021
30 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$106M
Last Round
N/A

Get the full picture

Create a free account to unlock Ray Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required